Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00007657 |
Recruitment Status
:
Completed
First Posted
: January 4, 2001
Last Update Posted
: June 15, 2009
|
Sponsor:
VA Office of Research and Development
Collaborators:
Medical Research Council of Canada
Merck Sharp & Dohme Corp.
Pfizer
GE Healthcare
Bristol-Myers Squibb
Astellas Pharma Inc
AstraZeneca
Sanofi
Datascope Corp.
First Horizon
Kos
Key Pharmaceuticals
Integrated Therapeutics Group
Hoest-Marion-Roussel
Information provided by:
VA Office of Research and Development
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Primary Completion Date : | No date given |
Actual Study Completion Date : | June 2006 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):